NJ Pharma Co. Revives Lupus Product Row With FDA
By Jeannie O'Sullivan ( July 27, 2015, 7:37 PM EDT) -- A New Jersey pharmaceutical firm has accused the U.S. Food & Drug Administration of reneging on a promise to relax threats to seize a lupus product after the two sides sparred before a judge over the product's labeling as a medical food....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.